| |
Pregabalin
|
Duloxetine
| |
|---|
| |
N = 446
|
N = 446
| |
|---|
| |
n
|
%
|
n
|
%
|
P value*
|
|---|
|
Age, years (categorical)
| | | | |
0.1304
|
|
18-29
|
0
|
0.0
|
0
|
0.0
| |
|
30-39
|
7
|
1.6
|
1
|
0.2
|
|
40-49
|
27
|
6.1
|
26
|
5.8
|
|
50-59
|
73
|
16.4
|
86
|
19.3
|
|
60-69
|
144
|
32.3
|
159
|
35.7
|
|
70-79
|
150
|
33.6
|
126
|
28.3
|
|
80-89
|
45
|
10.1
|
48
|
10.8
|
|
Gender
| | | | |
0.5854
|
|
Male
|
185
|
41.5
|
177
|
39.7
| |
|
Female
|
261
|
58.5
|
269
|
60.3
|
|
Race/Ethnicity
| | | | |
0.7265
|
|
White
|
363
|
81.4
|
353
|
79.1
| |
|
Black
|
58
|
13.0
|
69
|
15.5
|
|
Hispanic
|
13
|
2.9
|
14
|
3.1
|
|
Other
|
12
|
2.7
|
10
|
2.2
|
|
Geographic Region
| | | | |
0.6759
|
|
Northeast
|
5
|
1.1
|
5
|
1.1
| |
|
Midwest
|
78
|
17.5
|
78
|
17.5
|
|
South
|
338
|
75.5
|
333
|
74.7
|
|
West
|
25
|
5.6
|
30
|
6.7
|
|
Low Income Status
|
87
|
19.5
|
92
|
20.6
|
0.6814
|
|
Dual Eligibility Status
|
52
|
11.7
|
56
|
12.6
|
0.6759
|
| |
Mean
|
SD
|
Mean
|
SD
| |
|
Age, years (continuous)
|
66.7
|
10.7
|
66.7
|
10.4
|
0.5924
|
|
Propensity Score
|
0.47
|
0.14
|
0.47
|
0.14
|
0.9931
|
- *All P values for categorical variables calculated using chi -square tests. All P values for continuous variables calculated using Wilcoxon rank-sum tests.
- SD, Standard Deviation.
